{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:29:02Z","timestamp":1792146542057,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]},{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]},{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]},{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]},{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]},{"name":"the Science and Technology plan project in Zunyi","award":["No.HZ(2023)37"],"award-info":[{"award-number":["No.HZ(2023)37"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01814-9","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:09:27Z","timestamp":1753855767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of USP11 regulated SIRT3\/ROS in drug resistance of acute myeloid leukemia"],"prefix":"10.1007","volume":"25","author":[{"given":"Pinwei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinLi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhencang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1186\/s12967-024-05705-7","volume":"22","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Bai X, Guo S, Zhang X, Liu J, Zhao M, Xie T, Meng H, Zhang Y, He X, Zhao M. Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia. J Transl Med. 2024;22:888.","journal-title":"J Transl Med"},{"issue":"2","key":"1814_CR2","doi-asserted-by":"publisher","first-page":"oyae246","DOI":"10.1093\/oncolo\/oyae246","volume":"30","author":"S Casta\u00f1o-D\u00edez","year":"2024","unstructured":"Casta\u00f1o-D\u00edez S, \u00c1lamo JR, L\u00f3pez-Guerra M, G\u00f3mez-Hernando M, Zugasti I, Jim\u00e9nez-Vicente C, Guijarro F, L\u00f3pez-Oreja I, Esteban D, Charry P, Torrecillas V, Mont-de Torres L, Cort\u00e9s-Bullich A, Bataller \u00c1, Guardia A, Mun\u00e1rriz D, Carcelero E, Riu G, Triguero A, Tovar N, Vela D, Be\u00e0 S, Costa D, Colomer D, Rozman M, Esteve J, D\u00edaz-Bey\u00e1 M. Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia? Oncol. 2024;30(2):oyae246.","journal-title":"Oncol"},{"key":"1814_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107586","volume":"147","author":"R Chen","year":"2024","unstructured":"Chen R, AlHumaid M, Daher-Reyes G, Atenafu EG, Chan S, Gupta V, Maze D, Schuh AC, Minden MD, Yee K, Schimmer AD, Sibai H. Outcome of adolescents and young adult acute myeloid leukemia patients compared with middle-aged patients: a single centre retrospective experience. Leuk Res. 2024;147: 107586.","journal-title":"Leuk Res"},{"key":"1814_CR4","first-page":"e00207","volume":"6","author":"DX Deng","year":"2024","unstructured":"Deng DX, Ma XH, Wu ZH, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Huang XJ, Zhao XS, Mo XD. Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (KMT2A) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantation. Blood Sci (Baltimore, Md). 2024;6:e00207.","journal-title":"Blood Sci (Baltimore, Md)"},{"key":"1814_CR5","doi-asserted-by":"publisher","first-page":"113416","DOI":"10.1016\/j.biopha.2022.113416","volume":"153","author":"J Shi","year":"2022","unstructured":"Shi J, Sun S, Xing S, Huang C, Huang Y, Wang Q, Xue X, Chen Z, Wang Y, Huang Z. Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway. Biomed Pharmacother = Biomed Pharmacother. 2022;153:113416.","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"issue":"11","key":"1814_CR6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3390\/antiox12112008","volume":"12","author":"RH Fu","year":"2023","unstructured":"Fu RH. Pectolinarigenin improves oxidative stress and apoptosis in mouse NSC-34 motor neuron cell lines induced by C9-ALS-associated proline-arginine dipeptide repeat proteins by enhancing mitochondrial fusion mediated via the SIRT3\/OPA1 axis. Antioxidants. 2023;12(11):2008.","journal-title":"Antioxidants"},{"key":"1814_CR7","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1245\/s10434-020-09373-x","volume":"28","author":"M Paku","year":"2021","unstructured":"Paku M, Haraguchi N, Takeda M, Fujino S, Ogino T, Takahashi H, Miyoshi N, Uemura M, Mizushima T, Yamamoto H, Doki Y, Eguchi H. SIRT3-mediated SOD2 and PGC-1\u03b1 contribute to chemoresistance in colorectal cancer cells. Ann Surg Oncol. 2021;28:4720.","journal-title":"Ann Surg Oncol"},{"key":"1814_CR8","doi-asserted-by":"publisher","first-page":"165801","DOI":"10.1016\/j.bbadis.2020.165801","volume":"1866","author":"C Cort\u00e9s-Rojo","year":"2020","unstructured":"Cort\u00e9s-Rojo C, Vargas-Vargas MA, Olmos-Orizaba BE, Rodr\u00edguez-Orozco AR, Calder\u00f3n-Cort\u00e9s E. Interplay between NADH oxidation by complex I, glutathione redox state and sirtuin-3, and its role in the development of insulin resistance. Biochim Biophys Acta. 2020;1866:165801.","journal-title":"Biochim Biophys Acta"},{"key":"1814_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122187","volume":"333","author":"J Chen","year":"2023","unstructured":"Chen J, Wang Q, Li R, Li Z, Jiang Q, Yan F, Ye J. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus. Life Sci. 2023;333: 122187.","journal-title":"Life Sci"},{"key":"1814_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s10020-024-01061-w","volume":"31","author":"B Gao","year":"2025","unstructured":"Gao B, Jing Y, Li X, Cong S. Ubiquitin specific peptidase 11 knockdown slows Huntington\u2019s disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway. Mol Med (Cambridge, Mass). 2025;31:7.","journal-title":"Mol Med (Cambridge, Mass)"},{"key":"1814_CR11","doi-asserted-by":"publisher","first-page":"119883","DOI":"10.1016\/j.bbamcr.2024.119883","volume":"1872","author":"M Ebina","year":"2025","unstructured":"Ebina M, Miura Y, Sakane F. Ubiquitin-specific peptidase 11 selectively interacts with and deubiquitination-dependently stabilizes diacylglycerol kinase \u03b4 to maintain cellular glucose uptake. Biochim Biophys Acta. 2025;1872:119883.","journal-title":"Biochim Biophys Acta"},{"key":"1814_CR12","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s44321-024-00146-7","volume":"16","author":"Y Guo","year":"2024","unstructured":"Guo Y, Cai C, Zhang B, Tan B, Tang Q, Lei Z, Qi X, Chen J, Zheng X, Zi D, Li S, Tan J. Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice. EMBO Mol Med. 2024;16:2856.","journal-title":"EMBO Mol Med"},{"key":"1814_CR13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/jf3050268","volume":"61","author":"H Xiao","year":"2013","unstructured":"Xiao H, Wang J, Yuan L, Xiao C, Wang Y, Liu X. Chicoric acid induces apoptosis in 3T3-L1 preadipocytes through ROS-mediated PI3K\/Akt and MAPK signaling pathways. J Agric Food Chem. 2013;61:1509.","journal-title":"J Agric Food Chem"},{"key":"1814_CR14","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1021\/acs.jafc.1c06223","volume":"70","author":"Z Pu","year":"2022","unstructured":"Pu Z, Shen C, Zhang W, Xie H, Wang W. Avenanthramide C from oats protects pyroptosis through dependent ROS-induced mitochondrial damage by PI3K ubiquitination and phosphorylation in pediatric pneumonia. J Agric Food Chem. 2022;70:2339.","journal-title":"J Agric Food Chem"},{"issue":"4","key":"1814_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood.2024024968","volume":"145","author":"S Kyt\u00f6l\u00e4","year":"2025","unstructured":"Kyt\u00f6l\u00e4 S, V\u00e4nttinen I, Ruokoranta T, Partanen A, Holopainen A, Saad J, Kontro M. Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial. Blood. 2025;145(4):409\u201321.","journal-title":"Blood"},{"key":"1814_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02417-1","author":"SA Patel","year":"2024","unstructured":"Patel SA. Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia. Leukemia. 2024. https:\/\/doi.org\/10.1038\/s41375-024-02417-1.","journal-title":"Leukemia"},{"key":"1814_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12964-024-01926-x","volume":"22","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zeng J, Liu K, Li D, Huang S, Fu S, Ye M, Tao S, Wu J. USP11 promotes lipogenesis and tumorigenesis by regulating SREBF1 stability in hepatocellular carcinoma. Cell Commun Signal. 2024;22:550.","journal-title":"Cell Commun Signal"},{"key":"1814_CR18","first-page":"2400620","volume":"29","author":"G Zhu","year":"2024","unstructured":"Zhu G, Cai J, Fu W, Sun Y, Wang T, Zhong H. Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation. Hematology (Amsterdam, Netherlands). 2024;29:2400620.","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"1814_CR19","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1007\/s00432-023-05029-x","volume":"149","author":"J Yang","year":"2023","unstructured":"Yang J, Li L, Cheng J, Lu J, Zhang S, Wang S, Zhao L, Zhou L. The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia. J Cancer Res Clin Oncol. 2023;149:11457.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1814_CR20","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.7150\/jca.52158","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun H, Wang R, Liu Y, Mei H, Liu X, Peng Z. USP11 induce resistance to 5-fluorouracil in colorectal cancer through activating autophagy by stabilizing VCP. J Cancer. 2021;12:2317.","journal-title":"J Cancer"},{"key":"1814_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-023-06325-7","volume":"14","author":"X Liao","year":"2023","unstructured":"Liao X, Cai D, Liu J, Hu H, You R, Pan Z, Chen S, Xu K, Dai W, Zhang S, Lin X, Huang H. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. Cell Death Dis. 2023;14:796.","journal-title":"Cell Death Dis"},{"key":"1814_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","volume":"31","author":"W Du","year":"2024","unstructured":"Du W, Huang Y, Chen X, Deng Y, Sun Y, Yang H, Shi Q, Wu F, Liu G, Huang H, Ding J, Huang X, Xu S. Discovery of a PROTAC degrader for METTL3-METTL14 complex. Cell Chem Biol. 2024;31:177.","journal-title":"Cell Chem Biol"},{"key":"1814_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41419-022-05435-y","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Li M, Xia Y, Li G, Su X, Wang D, Ye J, Lu F, Sun T, Ji C. HDAC1\/3-dependent moderate liquid-liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation. Cell Death Dis. 2022;13:992.","journal-title":"Cell Death Dis"},{"key":"1814_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41419-023-05915-9","volume":"14","author":"J Duan","year":"2023","unstructured":"Duan J, Huang D, Liu C, Lv Y, Zhang L, Chang F, Zeng X, Li L, Wang W, Shao G. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1. Cell Death Dis. 2023;14:402.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1814_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41374-019-0332-8","volume":"100","author":"J Wu","year":"2020","unstructured":"Wu J, Deng Z, Sun M, Zhang W, Yang Y, Zeng Z, Chen Z. Polydatin protects against lipopolysaccharide-induced endothelial barrier disruption via SIRT3 activation. Lab Investig. 2020;100(4):643\u201356.","journal-title":"Lab Investig"},{"key":"1814_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154556","volume":"109","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Ren J, Wang F, Li M, Pan M, Zhang H, Qu F. Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling. Phytomedicine. 2023;109: 154556.","journal-title":"Phytomedicine"},{"key":"1814_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158282","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Shen Y, Wei W, Wang W, Jiang D, Ren Y, Peng Z, Fan Q, Cheng J, Ma J. Dysregulation of SIRT3 SUMOylation confers AML chemoresistance via controlling HES1-dependent fatty acid oxidation. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158282.","journal-title":"Int J Mol Sci"},{"key":"1814_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117019","volume":"489","author":"D Zhu","year":"2024","unstructured":"Zhu D, Shi C, Sun S, Chen X, Xu Y, Wang B, Xu Z, Zhang P, Sun M. The SIRT3\/GSK-3\u03b2\/GLUT4 axis might be involved in maternal hypoxia-induced skeletal muscle insulin resistance in old male rat offspring. Toxicol Appl Pharmacol. 2024;489: 117019.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1814_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111996","volume":"222","author":"E \u0160imuni\u0107","year":"2024","unstructured":"\u0160imuni\u0107 E, Podgorski II, Pinteri\u0107 M, Had\u017eija MP, Belu\u017ei\u0107 R, Parad\u017eik M, Don\u010devi\u0107 L, Balog T, Kaloper M, Habisch H, Madl T, Kora\u0107 A, Sobo\u010danec S. Sirtuin 3 drives sex-specific responses to age-related changes in mouse embryonic fibroblasts. Mech Ageing Dev. 2024;222: 111996.","journal-title":"Mech Ageing Dev"},{"key":"1814_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060810","author":"M Aventaggiato","year":"2024","unstructured":"Aventaggiato M, Arcangeli T, Vernucci E, Barreca F, Sansone L, Pellegrini L, Pontemezzo E, Valente S, Fioravanti R, Russo MA, Mai A, Tafani M. Pharmacological activation of SIRT3 modulates the response of cancer cells to acidic pH. Pharmaceuticals. 2024. https:\/\/doi.org\/10.3390\/ph17060810.","journal-title":"Pharmaceuticals"},{"key":"1814_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102707","volume":"62","author":"J Zhu","year":"2023","unstructured":"Zhu J, Sun R, Sun K, Yan C, Jiang J, Kong F, Shi J. The deubiquitinase USP11 ameliorates intervertebral disc degeneration by regulating oxidative stress-induced ferroptosis via deubiquitinating and stabilizing Sirt3. Redox Biol. 2023;62: 102707.","journal-title":"Redox Biol"},{"key":"1814_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038897","volume":"103","author":"J Ma","year":"2024","unstructured":"Ma J, Zhao H, Ge F. Application of m6A regulators to predict transformation from myelodysplastic syndrome to acute myeloid leukemia via machine learning. Medicine (Baltimore). 2024;103: e38897.","journal-title":"Medicine (Baltimore)"},{"key":"1814_CR33","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.csbj.2024.02.029","volume":"23","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang L, Li J, Feng R, Li C, Liu Y, Sun G, Xiao F, Zhang C. Comprehensive analysis of m(6)A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing. Comput Struct Biotechnol J. 2024;23:1144.","journal-title":"Comput Struct Biotechnol J"},{"key":"1814_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/jleuko\/qiae106","volume":"116","author":"Z Fang","year":"2024","unstructured":"Fang Z, Ding H, Han J, Fu L, Jin J, Feng W. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. J Leukoc Biol. 2024;116:662.","journal-title":"J Leukoc Biol"},{"key":"1814_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111304","volume":"122","author":"M Zhang","year":"2024","unstructured":"Zhang M, Xie Z, Tan Y, Wu Y, Wang M, Zhang P, Yuan Y, Li J. METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression. Cell Signal. 2024;122: 111304.","journal-title":"Cell Signal"},{"key":"1814_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/CM9.0000000000003073","volume":"137","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma Y, Yu J, Su R, Wang X. Internal m 6 A and m 7 G RNA modifications in hematopoietic system and acute myeloid leukemia. Chin Med J (Engl). 2024;137:1033.","journal-title":"Chin Med J (Engl)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01814-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:50:20Z","timestamp":1764917420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01814-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01814-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflicts of interest regarding this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Ethics Committee of The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University). All animal experiment procedures were performed in accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, formulated by the Ministry of Science and Technology of China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All patients were informed and signed informed consent voluntarily. This study was complied with the guidelines outlined in the declaration of Helsinki which were followed. The written consent was received from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"267"}}